Uso de la polipíldora cardiovascular en la prevención secundaria de la enfermedad cerebrovascular-Reference-Cited by-同舟云学术

Uso de la polipíldora cardiovascular en la prevención secundaria de la enfermedad cerebrovascular

Published:2021-01 Issue:1 Volume:36 Page:1-8
ISSN:0213-4853
Container-title:Neurología
language:es
Short-container-title:Neurología

Author:

Masjuan J.,Gállego J.,Aguilera J.M.,Arenillas J.F.,Castellanos M.,Díaz F.,Portilla J.C.,Purroy F.

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference53 articles.

1. Instituto Nacional de Estadística 2012. [consultado 14 Feb 2017]. Disponible en: http://www.ine.es

2. Organización Mundial de la Salud. Enfermedades cardiovasculares. Nota descriptiva. Ene de 2015. [consultado 4 abr 2017]. Disponible en: http://www.who.int/mediacentre/factsheets/fs317/es/.

3. [An alarming threat to secondary prevention: Low compliance (lifestyle) and poor adherence (drugs)] [artículo en español];Fuster;Rev Esp Cardiol (Engl Ed).,2012

4. A step ahead in secondary prevention of cardiovascular risk. Consensus document on clinical use of the polypill;Gonzalez-Juanatey;Rev Esp Cardiol (Engl Ed).,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report;BMC Proceedings;2023-08-17

2. Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke;Phytomedicine;2022-05

3. Cardiovascular prevention in elderly patients;J GERIATR CARDIOL;2022

4. Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients;Cerebrovascular Diseases Extra;2020-11-11